QC
BVS icon

Quadrature Capital’s Bioventus BVS Stock Holding History

Quadrature Capital’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55,353
Closed -$318K – 998
2024
Q2 		$318K Buy
+55,353
New +$304K 0.01% 803
2024
Q1 		– Sell
-16,031
Closed -$84.8K – 1224
2023
Q4 		$84.8K Buy
+16,031
New +$63.4K ﹤0.01% 1080

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Quadrature Capital's BVS Position: Q3 2024 in Review

Quadrature Capital sold out of Bioventus (BVS) in Q3 2024, closing a stake of 55,353 shares — an estimated $318K sold.

Quadrature Capital first reported a position in BVS in Q4 2023 and held it in 2 quarters. The position peaked at $318K in Q2 2024. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Quadrature Capital reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Quadrature Capital sold 55,353 Bioventus shares in Q3 2024, an estimated $318K.
  • Quadrature Capital first reported a position in Bioventus in Q4 2023 and held it in 2 quarters.
  • Quadrature Capital's Bioventus position peaked at $318K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Quadrature Capital's 13F filing for Q3 2024, filed 14 Nov 2024.